MGMT and glioblastoma: Ellingson et al. showed in 1,054 glioblastoma patients (with partially available data on IDH mutation and MGMT methylation) that smaller residual CE tumor volumes (<12 cm3) and MGMT methylation were significantly associated with longer overall survival in patients receiving chemoradiation (18).